Beijing Centergate Technologies (000931.SZ): Registration application for Non-Pravastatin tablets has been accepted.
Zhongguancun (000931.SZ) announcement, the company's subsidiary Duoduo Pharmaceutical Co., Ltd. (Duoduo Pharmaceutical for short) ...
Beijing Centergate Technologies(000931.SZ) announced that its subsidiary company, Duoduo Pharmaceutical Co., Ltd. (referred to as Duoduo Pharma), recently received a "Notice of Acceptance" issued by the National Medical Products Administration for the registration application of Febuxostat tablets (specifications: 20mg, 40mg). The indication for this application is for the long-term treatment of hyperuricemia in gout patients, and it is not recommended for hyperuricemia without clinical symptoms.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
